Literature DB >> 528998

Comparison of dopamine synthesis regulation in the terminals of nigrostriatal, mesolimbic, tuberoinfundibular and tuberohypophyseal neurons.

K T Demarest, K E Moore.   

Abstract

The rate of accumulation of DOPA after the administration of decarboxylase inhibitor (NSD 1015) was determined in the striatum, olfactory tubercle, median eminence and posterior pituitary of the rat brain in order to obtain an index of the rate of synthesis of dopamine (DA) in the terminals of nigrostriatal, mesolimbic, tuberoinfundibular and tuberohypophyseal neurons, respectively. In all brain regions an increase in the concentration of DA by the administration of a monoamine oxidase inhibitor decreased DOPA accumulation while a decrease in the concnetration of DA by the administration of reserpine increased DOPA accumulation. These results indicate that end product inhibition plays a role in regulating DA synthesis in all four neuronal systems. Injections of DA agonists decreased and DA antagonists increased the accumulation of DOPA instriatum, olfactory tubercle and posterior pituitary, but not in median eminence. The administration of gamma-butyrolactone (GBL) and baclofen increased the concentration of DA and the accumulation of DOPA in the striatum, olfactory tubercle and posterior pituitary, and these effects were reversed by the administration of apomorphine. On the other hand, GBL and baclofen had no effect on the concentration of DA or the accumulation of DOPA in the median eminence. These two drugs did, however, reduce the alpha-methyltyrosine-induced decline of DA in the median eminence suggesting that they inhibit the activity of tuberoinfundibular nerves just as they do DA nerves in other systems. These results suggest that the regulation of DA synthesis in terminals of nigrostriatal, mesolimbic and tuberohypophyseal nerves is different from that in tuberoinfundibular nerves in that the latter nerves appear to lack an autoreceptor regulatory mechanism.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 528998     DOI: 10.1007/BF01259333

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  26 in total

1.  TYROSINE HYDROXYLASE. THE INITIAL STEP IN NOREPINEPHRINE BIOSYNTHESIS.

Authors:  T NAGATSU; M LEVITT; S UDENFRIEND
Journal:  J Biol Chem       Date:  1964-09       Impact factor: 5.157

2.  Baclofen and gamma-hydroxybutyrate: similar effects on cerebral dopamine neurones.

Authors:  M Da Prada; H H Keller
Journal:  Life Sci       Date:  1976-10-15       Impact factor: 5.037

Review 3.  Simple neuronal models to estimate turnover rate of noradrenergic transmitters in vivo.

Authors:  E Costa
Journal:  Adv Biochem Psychopharmacol       Date:  1970

4.  Letter: Catecholamines in the median eminence: new evidence for a major noradrenergic input.

Authors:  A C Cuello; A S Horn; A V Mackay; L L Iversen
Journal:  Nature       Date:  1973-06-22       Impact factor: 49.962

5.  Castration, sex hormones, and tubero-infundibular dopamine neurons.

Authors:  K Fuxe; T Hökfelt; O Nilsson
Journal:  Neuroendocrinology       Date:  1969       Impact factor: 4.914

6.  Factors involved in the control of the activity of the tubero-infundibular dopamine neurons during pregnancy and lactation.

Authors:  K Fuxe; T Hökfelt; O Nilsson
Journal:  Neuroendocrinology       Date:  1969       Impact factor: 4.914

7.  In-vivo measurements of tryptophan and tyrosine hydroxylase activities in mouse brain.

Authors:  A Carlsson; M Lindqvist
Journal:  J Neural Transm       Date:  1973       Impact factor: 3.575

8.  Accumulation of L-dopa in the median eminence: an index of tuberoinfundibular dopaminergic nerve activity.

Authors:  K T Demarest; K E Moore
Journal:  Endocrinology       Date:  1980-02       Impact factor: 4.736

9.  Tolerance to the effects of baclofen and gamma-butyrolactone on locomotor activity and dopaminergic neurons in the mouse.

Authors:  G Gianutsos; K E Moore
Journal:  J Pharmacol Exp Ther       Date:  1978-12       Impact factor: 4.030

10.  Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain.

Authors:  J Glowinski; L L Iversen
Journal:  J Neurochem       Date:  1966-08       Impact factor: 5.372

View more
  27 in total

1.  Reversal of motor impairments in parkinsonian rats by continuous intrastriatal delivery of L-dopa using rAAV-mediated gene transfer.

Authors:  Deniz Kirik; Biljana Georgievska; Corinna Burger; Christian Winkler; Nicholas Muzyczka; Ronald J Mandel; Anders Bjorklund
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-26       Impact factor: 11.205

Review 2.  Basic biology of clozapine: electrophysiological and neuroendocrinological studies.

Authors:  G A Gudelsky; J F Nash; S A Berry; H Y Meltzer
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

3.  Dopaminergic toxicity of the herbicide atrazine in rat striatal slices.

Authors:  Nikolay M Filipov; Molly A Stewart; Russell L Carr; Shannon C Sistrunk
Journal:  Toxicology       Date:  2006-12-15       Impact factor: 4.221

4.  On the presence of autoreceptors on dopamine neurons in different brain regions.

Authors:  N E Andén; M Grabowska-Andén; B Liljenberg
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

5.  Demonstration of autoreceptors on dopamine neurons in different brain regions of rats treated with gammabutyrolactone.

Authors:  N E Andén; M Grabowska-Andén; B Liljenberg
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

6.  Endogenous dopamine release from tuberoinfundibular neurons: does calmodulin play any role?

Authors:  G F Di Renzo; S Amoroso; M Taglialatela; L Annunziato
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-07       Impact factor: 3.000

7.  Effect of buspirone on rat plasma prolactin levels and striatal dopamine turnover.

Authors:  H Y Meltzer; M Simonovic; V S Fang; G A Gudelsky
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

8.  The role of de novo catecholamine synthesis in mediating methylmercury-induced vesicular dopamine release from rat pheochromocytoma (PC12) cells.

Authors:  Chelsea T Tiernan; Ethan A Edwin; John L Goudreau; William D Atchison; Keith J Lookingland
Journal:  Toxicol Sci       Date:  2013-02-19       Impact factor: 4.849

9.  Regulation of the synthesis and metabolism of striatal dopamine after disruption of nerve conduction in the medial forebrain bundle.

Authors:  J W Commissiong; C Slimovitch; G Toffano
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

10.  Effect of a reversible and selective MAO-A inhibitor (cimoxatone) on diurnal variation in plasma prolactin level in man.

Authors:  M Strolin Benedetti; A Eschalier; A Lesage; G Dordain; V Rovei; E Zarifian; P Dostert
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.